MDsim Closes €2.3 Million Seed Round to Launch SPINEsim
MDsim Closes €2.3 Million Seed Round to Launch SPINEsim
MDsim, the medical technology startup developing Software as a Medical Device (SaMD) solutions for back pain prevention and spine surgery planning, is proud to announce the successful closing of its oversubscribed €2.3 million seed funding round.
The round was led by Kadmos Capital, a UK-based venture capital firm focusing on deep tech including breakthrough health tech innovations. Joining Kadmos were Astorg Philanthropy Investments, represented and managed by the Fondation Roi Baudouin, along with a diverse group of new and existing business angels and family offices from across the globe who share MDsim’s vision for transforming spine care.
“From the moment we met the founders, it was clear they were building an impactful company. At Kadmos, we were impressed by MDSim’s approach in building simulations to predict spinal conditions using a combination of computer modeling, data and AI. With Richard’s unparalleled expertise in spine surgery and Roger’s infectious drive, relentless energy and operational experience, we had no hesitation in backing their bold and ambitious mission”.
Remy Kesrouani, Managing Partner at Kadmos Capital.
During our direct fundraising campaign, we received strong interest from the general community in MDsim’s mission. In response, we decided to open our cap table to everyone through a crowdfunding campaign in partnership with Capital Cell, a specialized platform for health focused startups. This initiative brought more than 75 individual investors, all committed to supporting the mission of improving the lives of people suffering from back pain.
“We are thrilled and honored by the trust shown by Kadmos Capital, Astorg Philanthropy Investments, and our international community of angel investors, friends and family”, said Roger Assaker, Co-founder and CEO of MDsim. “This funding marks a crucial milestone in our journey to deliver patient-specific digital twin technologies that empower clinicians and optimize spine surgery outcomes.”
The seed funding will enable MDsim to bring to market the first release of two of its SaMD products, designed to assist spine surgeons in planning interventions and preventing degenerative conditions through data-driven, personalized simulations. With back pain being the leading cause of disability worldwide, MDsim is positioning itself at the intersection of advanced biomechanics, AI, and clinical decision support to reshape how spine care is delivered.
About MDsim
MDsim is a medtech innovator developing regulatory-grade Software as a Medical Device (SaMD) solution that generate patient-specific biomechanical digital twins of the spine. These digital models are used to help preventing spine degeneration and guide spine care professionals in planning and optimizing treatment. Headquartered in Belval (Luxembourg), MDsim is on a mission to transform spine care and improve lives worldwide.
You May Also Like
MDsim Showcases at LSI Europe ’24, shaping the Future of MedTech
Last month, our CEO, Roger Assaker, represented MDsim at the LSI Europe ’24, a premier event f
MDsim CEO Roger Assaker Joins SRS 59th Annual Meeting in Barcelona
MDsim’s CEO, Roger Assaker, participated in the Scoliosis Research Society’s (SRS) 59th Annu
Enhancing Collaboration with CHU Lille at HealthTech Connexion Day
MDsim participated in the CHU HealthTech Connexion Day #3, held at the Grand Palais in Lille on Dece
Leave a Reply